Top News
Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price...
Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.
- Our Sponsors Ad -
